Research

And Grants

Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.

Submit Grant Application

Home > Research and Grants

The Cure Starts Now follows an extensive grant approval process to ensure your dollars make the biggest impact to homerun cancer research. Take comfort in knowing that The Cure Starts Now only funds: research that follows our mission, research that is non-duplicative, and research that is financially sound.

The Cure Starts Now has funded $25,395,277 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 167 grants at over 100 hospitals in 29 countries.




UPMC Children's Hospital – $50,000

Amount
$50,000.00
Date
September 2021

The Role of QPRT and NAD Pathways in DIPG Treatment Resistance

Grant Information

University of Queensland Diamantina Institute – $100,000

Amount
$100,000.00
Date
September 2021

Innovative Models of the Brain Microenvironment to Identify New Treatments for Medulloblastoma

Grant Information

Duke University Hospital – $50,000

Amount
$50,000.00
Date
September 2021

Identifying Oncolytic Viral Therapy Resistance Mechanisms in Brain Tumors

Grant Information

Funding of PBTCF 2021: PBTC-059 - $25,000

Amount
$25,000.00
Date
January 2021

Phase 1 Trial of Autologous HER2-specific CAR T cells in Pediatric Patients with Refractory or Recurrent Ependymoma

Grant Information

International DIPG/DMG Registry And Repository - $1,508,198

Amount
$1,508,198.00
Date
December 2020

Grant Information

Children's Cancer Institute - $99,251

Amount
$99,251.00
Date
September 2020

Discovering New Epigenetic Players in DIPG Oncogenesis

Grant Information

Northwestern Memorial Hospital - $110,000

Amount
$110,000.00
Date
September 2020

Development of Histone Demethylase Inhibitor Against DIPG

Grant Information

The Hospital for Sick Children - $100,000

Amount
$100,000.00
Date
September 2020

Methionne Deptrivation as a Therapeutic Strategy for Diffuse Intrinsic Pontine Glioma

Grant Information

Hunter Medical Research Institute - $145,640

Amount
$145,640.00
Date
September 2020

Combatt DMG: Combined Anti-tumor Targeting of Diffuse Midline Gliomas

Grant Information

CONNECT Consortium - $489,801.26

Amount
$489,801.00
Date
September 2020

CONNECT (COllaborative Network for NEurooncology Clinical Trials) Consortium

Grant Information

International DIPG/DMG Registry And Repository - $862,671

Amount
$862,671.00
Date
May 2020

Grant Information

Funding of PBTCF 2020: PBTC-058 - $25,000

Amount
$25,000.00
Date
January 2020

PBTC-058: Phase 2 Study of Intraventricular Omburtamab-based Radioimmunotherapy for Pediatric Patients with Recurrent Medulloblastoma and Ependymoma

Grant Information

Sydney Children's Hospital - $151,468

Amount
$151,468.00
Date
December 2019

Developing New Epigenetic Combination Treatments Against DIPG.

Grant Information

Oncoceutics ONC201 - $100,000

Amount
$100,000.00
Date
December 2019

Expansion of the ONC201 Compassionate Use.

Grant Information
Learn More

University of Sydney - $100,000

Amount
$100,000.00
Date
November 2019

Targeting hypoxia and mitochondrial metabolism with repurposing drugs as an approach of radiosensitization for diffuse intrinsic pontine gliomas.

Grant Information